These outcomes, together with a preceding report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 help the idea of targeting ACKR3 as a unique approach to modulate the opioid program, which could open up new therapeutic avenues for opioid-similar Diseases. (two) The health practitioner has https://johnh913bwo0.eqnextwiki.com/user